- Home
- APP vs JNJ Comparison
APP vs JNJ Comparison
Compare APP & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APP | JNJ |
|---|---|---|
| Founded | 2012 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.9B | 542.4B |
| IPO Year | 2021 | 2003 |
Fundamental Metrics
Financial Performance| Metric | APP | JNJ |
|---|---|---|
| Price | $465.34 | $239.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 20 |
| Target Price | ★ $694.44 | $238.20 |
| AVG Volume (30 Days) | 5.4M | ★ 7.4M |
| Earning Date | 05-06-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 2.36% |
| EPS Growth | ★ 115.23 | 90.50 |
| EPS | ★ 3.56 | 2.14 |
| Revenue | ★ $5,480,717,000.00 | N/A |
| Revenue This Year | $47.88 | $6.63 |
| Revenue Next Year | $29.14 | $7.43 |
| P/E Ratio | $131.15 | ★ $111.72 |
| Revenue Growth | ★ 16.38 | N/A |
| 52 Week Low | $325.69 | $151.01 |
| 52 Week High | $745.61 | $251.71 |
Technical Indicators
Market Signals| Indicator | APP | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 60.42 |
| Support Level | $362.60 | $233.83 |
| Resistance Level | $499.42 | $244.80 |
| Average True Range (ATR) | 29.81 | 4.69 |
| MACD | -10.82 | 0.50 |
| Stochastic Oscillator | 12.53 | 84.57 |
Price Performance
Historical ComparisonAbout APP Applovin Corporation
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.